Literature References

From Assay Guidance Wiki

1. Hilf G, Gierschik P, and Jakobs KH. Muscarinic acetylcholine receptor-stimulated binding of guanosine 5’-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. Eur. J. Biochem. 186: 725-731, 1989. pubmed | doi.
2. Lazareno S, and Birdsall NJM. Pharmacological characterization of acetylcholine-stimulated [35S]-GTPγS binding mediated by human muscarinic m1-m4 receptors: antagonist studies. Br. J. Pharmacol. 109: 1120-1127, 1993. doi.
3. DeLapp N, McKinzie J, Sawyer BD, Vandergriff A, Falcone J, McClure D, and Felder CC. Determination of [35S] guanosine-5’-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G-protein scintillation proximity assay. J. Pharmacol. Exp. Ther. 289: 946-955, 1999. doi.
4. Porter AC, Bymaster FP, DeLapp NW, Yamada M, Wess J, Hamilton SE, Nathanson N, Felder CC. M1 muscarinic receptor signaling in mouse hippocampus and cortex. Brain Res. 944: 82-89, 2002. doi.
5. Bymaster FP, Falcone J, Bauzon D, Kennedy JS, Schenk K, DeLapp NW, and Cohen ML. Potent antagonism of 5HT3 and 5HT6 receptors by olanzapine. Eur. J. Pharmacol. 430: 341-349, 2001. doi.
6. Pullar IA, Boot JR, Carney SL, Cohen ML, Colvin EM, Conway RG, Hardy CH, Lucaites VL, Nelson DL, Shenk KW, Tomlinson R, Wedley S. In vitro activity of LY303558, and inhibitor of the 5-hydroxytryptamine transporter with 5-HT (1B/1D/2) receptor antagonist properties. Eur. J. Pharmacol 432: 9-17, 2001. pubmed | doi.
7. Wainscott DB, Johnson KW, Phebus LA, Schaus JM, Nelson DL. Human 5-HT1F receptor-stimulated [35S]GTPγS binding: correlation with inhibition of guinea pig dural plasma protein extravasation. Eur. J. Pharmacol 352: 117-124, 1998. doi
8. Alper RH, Nelson DL. Characterization of 5-HT1A receptor-mediated [35S]GTPγS binding in rat hippocampal membranes. Eur. J. Pharmacol. 343: 303-312, 1998. doi
9. Gupta SK, Pillarisetti K, Thomas RA, and Aiyar N. Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1α: implications for development of selective CXCR4 antagonists. Immunology Letters 78: 29-34, 2001. doi
10. Cussac D, Newman-Tancrdi A, Duqueyroix D, Pasteau V, and Millan MJ. Differential activation of Gq/11 and Gi3 proteins at 5-HT2C receptors revealed by antibody captures assays: influence of receptor reserve and relationship to agonist-directed trafficking. Mol. Pharmacol. 62: 578-589, 2002.
11. Newman-Tancredi A, Cussac D, Marini L, and Millan MJ. Antibody Capture Assay Reveals Bell-Shaped Concentration-Response Isotherms for h5-HT1A Receptor-Mediated Gαi3 Activation: Conformational Selection by High-Efficacy Agonists, and Relationship to Trafficking of Receptor Signaling. Mol. Pharmacol. 62: 590-601, 2002.
12. Newman-Tancredi A, Cussac D, Marini L, Touzard M, and Millan MJ. hH5-HT1B receptor-mediated constitutive Gαi3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5HT. British J. Pharmacol. 138: 1077-1084, 2003.
13. Milligan G. Principles: Extending the utility of [35S]GTPγS binding assays. TIPS 24: 87-90, 2003.
14. Leff P, and Dougall IG. Further concerns over Cheng-Prusoff analysis. TIPS 14: 110-112, 1993.